Validation of the Meet-URO score in patients with metastatic renal cell carcinoma receiving first-line nivolumab and ipilimumab in the Italian Expanded Access Program
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer
Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective study.
Autorzy:
Fratino L; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy. Polesel J; Unit of Cancer Epidemiology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy. Giunta EF; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy. Maruzzo M; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy. ButiS; Oncology Unit, University Hospital of Parma, Parma, Italy.; Department of Medicine and Surgery, University of Parma, Parma, Italy. Hassan MA; Portsmouth Hospitals University NHS Trust, Portsmouth, PO6 3LY, UK.; Faculty of Science and Health, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, PO1 2UP, UK. Basso U; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy. Rebuzzi SE; Medical Oncology Unit, Ospedale San Paolo, Savona, Italy.; Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genova, Genoa, Italy. De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy. Cinausero M; Department of Oncology, ASUFC Santa Maria Della Misericordia, Udine, Italy. Lipari H; Division of Medical Oncology, Cannizzaro Hospital, Catania, Italy. Gamba T; Medical Oncology, Mauriziano Hospital, Turin, Italy. Bimbatti D; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padua, Italy. Dri A; Department of Oncology, ASUFC Santa Maria Della Misericordia, Udine, Italy.; Department of Medicine, University of Udine, Udine, Italy. Ermacora P; Department of Oncology, ASUFC Santa Maria Della Misericordia, Udine, Italy. Vignani F; Medical Oncology, Mauriziano Hospital, Turin, Italy. Fornarini G; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genoa, Italy. Rescigno P; Candiolo Cancer Institute, FPO-IRCCS, SP142, km 3,95, 10060, Candiolo, Turin, Italy. . Banna GL; Portsmouth Hospitals University NHS Trust, Portsmouth, PO6 3LY, UK.; Faculty of Science and Health, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, PO1 2UP, UK.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 28; Vol. 14 (1), pp. 4949. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:
Journal Article; Multicenter Study; Observational Study
Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate.
Autorzy:
Fiala O; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Hošek P; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Korunková H; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic. Hora M; Department of Urology, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic. Kolář J; Department of Urology, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic. Šorejs O; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Topolčan O; Department of Immunochemistry Diagnostics, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic. Filipovský J; 2nd Department of Internal Medicine, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic. Liška V; Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.; Department of Surgery, University Hospital in Pilsen, Charles University, Pilsen, Czech Republic. Santoni M; Oncology Unit, Macerata Hospital, Macerata, Italy. ButiS; Department of Medicine and Surgery, University Hospital of Parma, Parma, Italy.; Oncology Unit, University Hospital of Parma, Parma, Italy. Fínek J; Department of Oncology and Radiotherapeutics, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Jan 02. Date of Electronic Publication: 2024 Jan 02.
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors
Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Survival.
Autorzy:
Choucair K; Barbara Ann Karmanos Cancer Institute, Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA. Nebhan C; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA. Cortellini A; Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London SW7 2BX, UK.; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy. Hentzen S; Department of Medicine, Kansas University Medical Center, Kansas City, KS 66211, USA. Wang Y; The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Liu C; Department of Internal Medicine, Baylor College of Medicine, Houston, TX 77030, USA. Giusti R; Medical Oncology Unit, Azienda Ospedaliero Universitaria Sant'Andrea, 00189 Rome, Italy. Filetti M; Phase 1 Unit, Fondazione Policlinico Universitario Agostino Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 71013 Rome, Italy. Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione Pascale, 80131 Napoli, Italy. Vanella V; Istituto Nazionale Tumori IRCCS Fondazione Pascale, 80131 Napoli, Italy. Galetta D; Medical Thoracic Oncology Unit, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy. Catino A; Medical Thoracic Oncology Unit, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy. Al-Bzour N; UPMC Hillman Cancer Center, Department of Medicine, Division of Hematology and Oncology, University of Pittsburgh, Pittsburgh, PA 15232, USA. Saeed A; Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, VT 05401, USA. Cavalcante L; Novant Health Cancer Institute, Charlotte, NC 28204, USA. Pizzutilo P; Medical Thoracic Oncology Unit, IRCCS Istituto Tumori Giovanni Paolo II, 70124 Bari, Italy. Genova C; UOC Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.; Dipartimento di Medicina Interna e Specialità Mediche, Università degli Studi di Genova, 16126 Genova, Italy. Bersanelli M; Medical Oncology Unit, University Hospital of Parma, 43125 Parma, Italy. ButiS; Medicine and Surgery Department, University of Parma, 43121 Parma, Italy. Johnson DB; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA. Fulgenzi CAM; Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London SW7 2BX, UK.; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy. Pinato DJ; Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London SW7 2BX, UK. Radford M; Department of Medicine, Kansas University Medical Center, Kansas City, KS 66211, USA. Kim C; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA. Naqash AR; Medical Oncology/Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK 73019, USA. Saeed A; UPMC Hillman Cancer Center, Department of Medicine, Division of Hematology and Oncology, University of Pittsburgh, Pittsburgh, PA 15232, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Oct 19; Vol. 15 (20). Date of Electronic Publication: 2023 Oct 19.
Percutaneous Ablation of T1 Renal Masses: Comparative Local Control and Complications after Radiofrequency and Cryoablation.
Autorzy:
Bertolotti L; Section of Radiology, Department of Medicine and Surgery, University of Parma, Maggiore Hospital, Via Gramsci 14, 43126 Parma, PR, Italy. Segato F; G.B. Rossi University Hospital, University of Verona, 37134 Verona, VR, Italy. Pagnini F; Section of Radiology, Department of Medicine and Surgery, University of Parma, Maggiore Hospital, Via Gramsci 14, 43126 Parma, PR, Italy. ButiS; Department of Medicine and Surgery, University of Parma-Oncology Unit, University Hospital of Parma, Via Gramsci 14, 43126 Parma, PR, Italy. Casarin A; Department of Radiology, San Bassiano Hospital, 36061 Bassano del Grappa, VI, Italy. Celia A; Department of Urology, San Bassiano Hospital, 36061 Bassano del Grappa, VI, Italy. Ziglioli F; Department of Urology, Parma University Hospital, Via Gramsci 14, 43126 Parma, PR, Italy. Maestroni U; Department of Urology, Parma University Hospital, Via Gramsci 14, 43126 Parma, PR, Italy. Pedrazzi G; Centre of Statistic, Department of Medicine and Surgery, University of Parma, 43126 Parma, PR, Italy. Ascenti V; Postgraduate School of Radiodiagnostics, Policlinico Universitario, University of Milan, 20133 Milano, MI, Italy. Martini C; Department of Medicine and Surgery, University of Parma, Maggiore Hospital, Via Gramsci 14, 43126 Parma, PR, Italy. Cicero C; Department of Radiology, San Bassiano Hospital, 36061 Bassano del Grappa, VI, Italy. De Filippo M; Section of Radiology, Department of Medicine and Surgery, University of Parma, Maggiore Hospital, Via Gramsci 14, 43126 Parma, PR, Italy.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
